Study Index

GHK-Cu Study Index

GHK-Cu (Glycyl-L-Histidyl-L-Lysine plus Cu2+) is an endogenous copper-binding tripeptide found in human plasma, saliva, and urine, with plasma concentrations declining significantly between young adulthood and middle age. Its primary research mechanisms involve copper ion delivery to copper-dependent enzymes including superoxide dismutase, direct stimulation of fibroblast collagen synthesis, modulation of matrix metalloproteinase activity, and broad regulation of gene expression across inflammatory, repair, and antioxidant pathways in cell-based assays. Loren Pickart identified GHK-Cu as a plasma factor with tissue repair activity in 1973, and research has continued across wound healing, skin aging, and anti-inflammatory biology.

Studies Listed

6

Order GHK-Cu ($179)

Curated Study References

Click column headers to sort. PubMed links open in a new tab where available.

6 studies

Pickart et al.

2015, BioMed Research International

PMID ↗

Analysis of GHK-Cu effects on gene expression identified modulation of more than 4,000 human genes in cell-based assays, spanning antioxidant defense, inflammatory regulation, tissue remodeling, and aging pathways.

Finkley et al.

2015, BioMed Research International

PMID ↗

GHK-Cu was documented to activate multiple cellular regeneration pathways in skin models including collagen synthesis, antioxidant enzyme upregulation, and anti-inflammatory gene expression modulation.

Pickart et al.

2012, Journal of Biomaterials Science, Polymer Edition

GHK-Cu promoted significant collagen and glycosaminoglycan synthesis in aged skin fibroblast cultures and reduced MMPs that degrade the extracellular matrix, providing mechanistic support for its skin remodeling properties.

Gorouhi et al.

2009, Journal of Aging Science

Review documenting the role of copper peptides including GHK-Cu in collagen synthesis upregulation and extracellular matrix remodeling in aging skin, with evidence for reduced MMP activity and improved dermal structure in fibroblast models.

Maquart et al.

1988, FEBS Letters

PMID ↗

GHK-Cu stimulated collagen synthesis and glycosaminoglycan production in human fibroblast cultures and improved wound healing rates in a rabbit wound model, providing early clinical-adjacent evidence for its repair activity.

Pickart et al.

1973, Journal of Biological Chemistry

PMID ↗

First identification of GHK-Cu as a plasma tripeptide with growth-modulating activity, establishing the foundational framework for copper ion delivery as its primary biological mechanism.

All citations are for informational research reference purposes. Always verify directly via PubMed for current status.

Research Questions

Common questions about GHK-Cu research context, mechanism, and procurement.

What is GHK-Cu and what is its primary research mechanism?+
GHK-Cu is an endogenous copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine plus Cu2+) found in human plasma, saliva, and urine. Its primary research mechanism involves copper ion delivery to copper-dependent enzymes, direct stimulation of fibroblast collagen synthesis, and modulation of matrix metalloproteinase activity in cell-based assay models.
What gene expression research has been conducted on GHK-Cu?+
Pickart et al. (2015, BioMed Research International) documented GHK-Cu modulating the expression of more than 4,000 human genes in cell-based assays, spanning antioxidant defense, inflammatory regulation, tissue remodeling, and aging-related pathways. This breadth of gene expression activity is among the most widely cited aspects of GHK-Cu research.
What does the collagen synthesis research show for GHK-Cu?+
Maquart et al. (1988, FEBS Letters) documented GHK-Cu stimulating collagen synthesis and glycosaminoglycan production in human fibroblast cultures. Pickart et al. (2012) further showed GHK-Cu reducing matrix metalloproteinase activity alongside collagen upregulation in aged skin fibroblast models, suggesting dual remodeling activity.
Is GHK-Cu naturally occurring in the human body?+
Yes. GHK-Cu is an endogenous peptide present in human plasma, urine, and saliva, and was first identified by Loren Pickart in 1973 as a plasma factor with tissue repair-promoting properties. Plasma concentrations of GHK-Cu decline significantly between young adulthood and middle age according to published concentration studies.

Related Compound Comparisons

Explore how GHK-Cu compares to other research compounds.

GHK-Cu vs Epithalon →BPC-157 vs GHK-Cu →GHK-Cu vs TB-500 →

Source GHK-Cu

GHK-Cu is available from Spartan Peptides at least 98% HPLC-verified purity. Domestic US supply with same-day dispatch before 2 PM. For in-vitro research use only.

Order GHK-Cu ($179)

For in-vitro research use only. Not intended for human consumption.